SCHEMBL22069966

SCHEMBL22069966

c1ccc(-c2nc(-c3cccc(-c4ccc5c(ccc6c7ccccc7oc56)c4)c3)nc(-c3ccc4c(c3)oc3ccccc34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.41
▸ ALOX5 P09917 1/20 0.39
▸ MAPT P10636 7/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ HPGD P15428 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ TSHR P16473 3/20 0.38
▸ POLB P06746 2/20 0.38
▸ AHR P35869 1/20 0.38
▸ PLA2G2A P14555 2/20 0.38
▸ PLA2G4A P47712 2/20 0.38
▸ PLA2G10 O15496 1/20 0.38
▸ CYP1A1 P04798 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP1B1 Q16678 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ PRKDC P78527 2/20 0.37
▸ MMP12 P39900 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22071404 0.97 HCRTR1 (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL22879988 0.97 ALOX5 (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL25664888 0.96 HCRTR1 (0.39) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL22070027 0.96 PLA2G2A (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL24634398 0.96 PLA2G2A (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL23134249 0.96 PLA2G2A (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL22071478 0.96 PLA2G2A (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL23134132 0.96 PLA2G2A (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL22483255 0.96 PLA2G2A (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD
SCHEMBL22070031 0.96 PLA2G2A (0.41) HCRTR1ALOX5MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3664172-B1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-09-06 — — EP disclosed
US-20210091314-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-03-25 — — US disclosed
EP-3664172-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE Samsung SDI Co., Ltd. (KR) 2020-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210091314-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 HCRTR1 280/4885ALOX5 393/4885MAPT 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback